# pathway_0010: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0010.txt)

**Task:** `pathway`  
**Author key, unchanged:** **B** — Antifungal biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MLHLTPLIFLSLAMAAAVGVWGVFTWNGGFDEMDGIVASHQSTGILGLQHCPDLDRGLMSMVAFNLPVVGRNPIFPAGRRFMVQFLANVAVIPVILNTEGARAEPGSLVRYSTTWGLFSQMATSAVMCPLYGFWFVRQSGAKQTEGGTLRPLPPNKWVVPSSVLIGYGIPALLSFDPFQWGLDLQIRGILAFTLYPLCISLTARLMRKVSKKRGRSLSPEWNSTISYVAVGVVGMVSHLWYLGTGLTGYPLSGDAVSSVAGPTEVGRAAQLVLLFLQIDYVITFAAMLLLAWHELTRHQLVRSWRAAGTLAVGWLFLGPGATLAAAWALREQWLSRPRGVRGEIKQKPK

[Multiple Choices]
A. polypeptide chain elongation. .
B. Antifungal biosynthesis. .
C. tetrahydrofolate interconversion. .
D. Purine metabolism
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches UniProt entry P9WEG7, which annotates the protein as terpene cyclase rstn5 / a restricticin-biosynthesis cluster protein and assigns it to antifungal biosynthesis. The pathway annotation cites ECO:0000269 evidence linked to a 2021 publication, supporting choice B, though the primary paper was not independently reviewed here.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is strongly hydrophobic, consistent with a membrane-associated protein, but that feature does not distinguish antifungal biosynthesis from the listed alternatives.


**Missing item-specific fact**

> Identifying this protein as rstn5 in the restricticin biosynthesis cluster, or equivalent protein-specific functional evidence, is needed to select antifungal biosynthesis.


**Reason**

> The sequence and choices provide no meaningful general biological basis for identifying this specific pathway; the distinguishing fact is an external, protein-specific annotation or functional result.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied evidence assigns the matched protein to antifungal biosynthesis, and no competing choice is supported by the evidence.


### Important caveats

- The sequence match and UniProt annotations are reviewer-only evidence, not information provided to the evaluated model.
- The pathway annotation cites experimental evidence, but the cited primary publication was not independently assessed; the author's exact data-source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is strongly hydrophobic, consistent with a membrane-associated protein, but that feature does not distinguish antifungal biosynthesis from the listed alternatives.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "Identifying this protein as rstn5 in the restricticin biosynthesis cluster, or equivalent protein-specific functional evidence, is needed to select antifungal biosynthesis.",
    "reason": "The sequence and choices provide no meaningful general biological basis for identifying this specific pathway; the distinguishing fact is an external, protein-specific annotation or functional result."
  },
  "case_id": "pathway_0010",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches UniProt entry P9WEG7, which annotates the protein as terpene cyclase rstn5 / a restricticin-biosynthesis cluster protein and assigns it to antifungal biosynthesis. The pathway annotation cites ECO:0000269 evidence linked to a 2021 publication, supporting choice B, though the primary paper was not independently reviewed here."
  },
  "important_caveats": [
    "The sequence match and UniProt annotations are reviewer-only evidence, not information provided to the evaluated model.",
    "The pathway annotation cites experimental evidence, but the cited primary publication was not independently assessed; the author's exact data-source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence assigns the matched protein to antifungal biosynthesis, and no competing choice is supported by the evidence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0010",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches UniProt entry P9WEG7, which annotates the protein as terpene cyclase rstn5 / a restricticin-biosynthesis cluster protein and assigns it to antifungal biosynthesis. The pathway annotation cites ECO:0000269 evidence linked to a 2021 publication, supporting choice B, though the primary paper was not independently reviewed here.",
    "evidence_ids": ["C1", "C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is strongly hydrophobic, consistent with a membrane-associated protein, but that feature does not distinguish antifungal biosynthesis from the listed alternatives.",
    "missing_item_specific_fact": "Identifying this protein as rstn5 in the restricticin biosynthesis cluster, or equivalent protein-specific functional evidence, is needed to select antifungal biosynthesis.",
    "reason": "The sequence and choices provide no meaningful general biological basis for identifying this specific pathway; the distinguishing fact is an external, protein-specific annotation or functional result."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence assigns the matched protein to antifungal biosynthesis, and no competing choice is supported by the evidence."
  },
  "important_caveats": [
    "The sequence match and UniProt annotations are reviewer-only evidence, not information provided to the evaluated model.",
    "The pathway annotation cites experimental evidence, but the cited primary publication was not independently assessed; the author's exact data-source snapshot is unknown."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry P9WEG7 (sequence matched exactly, 349 AA) annotates this protein as 'Terpene cyclase rstn5' / 'Restricticin biosynthesis cluster protein 5' with PATHWAY: 'Antifungal biosynthesis' (ECO:0000269, experimental evidence from PubMed:33857369, a 2021 JACS paper on genome mining of CYP51-inhibitor biosynthetic gene clusters). The EC number 5.4.99.- (isomerase/cyclase) is consistent with a terpene cyclase. The antifungal designation derives from the biological activity of the product (restricticin inhibits CYP51, a fungal enzyme). The sequence match is exact in both current and historical (v2) records.

Citations as saved: [C1](#evidence-c1), [C3](#evidence-c3), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> Elimination is partially possible: the N-terminal signal peptide and multiple hydrophobic TM-like segments make this incompatible with soluble translation machinery (A), folate-metabolizing enzymes (C), or purine-pathway enzymes (D). However, positively arriving at the pathway name 'Antifungal biosynthesis' requires knowing that this specific terpene cyclase (rstn5) belongs to the restricticin biosynthetic gene cluster and that UniProt assigns the pathway label 'Antifungal biosynthesis' rather than the more generic 'terpene biosynthesis' or 'secondary metabolite biosynthesis.' The DDxxD/NDxxD terpene-cyclase motifs are not unambiguously identifiable in this 349-aa sequence by casual inspection.


**Missing item-specific fact**

> The specific UniProt pathway annotation 'Antifungal biosynthesis' for this terpene cyclase, which is a database-specific naming choice tied to the restricticin biosynthetic cluster (rstn5) and its CYP51-inhibitor product. Without this annotation, a reasoning model would more naturally propose 'terpene biosynthesis' or 'secondary metabolism' rather than the exact label 'Antifungal biosynthesis.'


**Reason**

> While general biological knowledge permits elimination of A, C, and D (the sequence clearly is not a ribosomal/elongation factor, folate enzyme, or purine enzyme), the positive identification of the specific pathway label 'Antifungal biosynthesis' depends on the UniProt annotation of this particular terpene cyclase. The pathway name is an annotation convention, not a self-evident deduction from sequence features alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The distractors A (polypeptide chain elongation), C (tetrahydrofolate interconversion), and D (purine metabolism) are clearly incompatible with a membrane-associated terpene cyclase from a fungal secondary-metabolite gene cluster. No other option is defensible for this sequence.


### Important caveats

- The evidence code ECO:0000269 indicates experimental evidence, but the underlying experiment (2021 JACS paper) primarily involved genome mining, heterologous expression, and chemical characterization; the 'antifungal' label reflects the product's biological activity rather than a dedicated antifungal-pathway assay.
- The pathway name 'Antifungal biosynthesis' is a UniProt-specific annotation convention; the same enzyme could reasonably be placed under 'terpene biosynthesis' or 'natural product biosynthesis' in other databases.
- The UniProt entry was first public in Feb 2025; the author's source snapshot is unknown, but the sequence matches both current (v4) and historical (v2) records.
- The terpene cyclase DDxxD/NDxxD motifs are not clearly identifiable by simple pattern matching in this sequence, making positive enzymatic classification from sequence alone difficult.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Elimination is partially possible: the N-terminal signal peptide and multiple hydrophobic TM-like segments make this incompatible with soluble translation machinery (A), folate-metabolizing enzymes (C), or purine-pathway enzymes (D). However, positively arriving at the pathway name 'Antifungal biosynthesis' requires knowing that this specific terpene cyclase (rstn5) belongs to the restricticin biosynthetic gene cluster and that UniProt assigns the pathway label 'Antifungal biosynthesis' rather than the more generic 'terpene biosynthesis' or 'secondary metabolite biosynthesis.' The DDxxD/NDxxD terpene-cyclase motifs are not unambiguously identifiable in this 349-aa sequence by casual inspection.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific UniProt pathway annotation 'Antifungal biosynthesis' for this terpene cyclase, which is a database-specific naming choice tied to the restricticin biosynthetic cluster (rstn5) and its CYP51-inhibitor product. Without this annotation, a reasoning model would more naturally propose 'terpene biosynthesis' or 'secondary metabolism' rather than the exact label 'Antifungal biosynthesis.'",
    "reason": "While general biological knowledge permits elimination of A, C, and D (the sequence clearly is not a ribosomal/elongation factor, folate enzyme, or purine enzyme), the positive identification of the specific pathway label 'Antifungal biosynthesis' depends on the UniProt annotation of this particular terpene cyclase. The pathway name is an annotation convention, not a self-evident deduction from sequence features alone."
  },
  "case_id": "pathway_0010",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C3",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry P9WEG7 (sequence matched exactly, 349 AA) annotates this protein as 'Terpene cyclase rstn5' / 'Restricticin biosynthesis cluster protein 5' with PATHWAY: 'Antifungal biosynthesis' (ECO:0000269, experimental evidence from PubMed:33857369, a 2021 JACS paper on genome mining of CYP51-inhibitor biosynthetic gene clusters). The EC number 5.4.99.- (isomerase/cyclase) is consistent with a terpene cyclase. The antifungal designation derives from the biological activity of the product (restricticin inhibits CYP51, a fungal enzyme). The sequence match is exact in both current and historical (v2) records."
  },
  "important_caveats": [
    "The evidence code ECO:0000269 indicates experimental evidence, but the underlying experiment (2021 JACS paper) primarily involved genome mining, heterologous expression, and chemical characterization; the 'antifungal' label reflects the product's biological activity rather than a dedicated antifungal-pathway assay.",
    "The pathway name 'Antifungal biosynthesis' is a UniProt-specific annotation convention; the same enzyme could reasonably be placed under 'terpene biosynthesis' or 'natural product biosynthesis' in other databases.",
    "The UniProt entry was first public in Feb 2025; the author's source snapshot is unknown, but the sequence matches both current (v4) and historical (v2) records.",
    "The terpene cyclase DDxxD/NDxxD motifs are not clearly identifiable by simple pattern matching in this sequence, making positive enzymatic classification from sequence alone difficult."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The distractors A (polypeptide chain elongation), C (tetrahydrofolate interconversion), and D (purine metabolism) are clearly incompatible with a membrane-associated terpene cyclase from a fungal secondary-metabolite gene cluster. No other option is defensible for this sequence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0010",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry P9WEG7 (sequence matched exactly, 349 AA) annotates this protein as 'Terpene cyclase rstn5' / 'Restricticin biosynthesis cluster protein 5' with PATHWAY: 'Antifungal biosynthesis' (ECO:0000269, experimental evidence from PubMed:33857369, a 2021 JACS paper on genome mining of CYP51-inhibitor biosynthetic gene clusters). The EC number 5.4.99.- (isomerase/cyclase) is consistent with a terpene cyclase. The antifungal designation derives from the biological activity of the product (restricticin inhibits CYP51, a fungal enzyme). The sequence match is exact in both current and historical (v2) records.",
    "evidence_ids": ["C1", "C3", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "Elimination is partially possible: the N-terminal signal peptide and multiple hydrophobic TM-like segments make this incompatible with soluble translation machinery (A), folate-metabolizing enzymes (C), or purine-pathway enzymes (D). However, positively arriving at the pathway name 'Antifungal biosynthesis' requires knowing that this specific terpene cyclase (rstn5) belongs to the restricticin biosynthetic gene cluster and that UniProt assigns the pathway label 'Antifungal biosynthesis' rather than the more generic 'terpene biosynthesis' or 'secondary metabolite biosynthesis.' The DDxxD/NDxxD terpene-cyclase motifs are not unambiguously identifiable in this 349-aa sequence by casual inspection.",
    "missing_item_specific_fact": "The specific UniProt pathway annotation 'Antifungal biosynthesis' for this terpene cyclase, which is a database-specific naming choice tied to the restricticin biosynthetic cluster (rstn5) and its CYP51-inhibitor product. Without this annotation, a reasoning model would more naturally propose 'terpene biosynthesis' or 'secondary metabolism' rather than the exact label 'Antifungal biosynthesis.'",
    "reason": "While general biological knowledge permits elimination of A, C, and D (the sequence clearly is not a ribosomal/elongation factor, folate enzyme, or purine enzyme), the positive identification of the specific pathway label 'Antifungal biosynthesis' depends on the UniProt annotation of this particular terpene cyclase. The pathway name is an annotation convention, not a self-evident deduction from sequence features alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The distractors A (polypeptide chain elongation), C (tetrahydrofolate interconversion), and D (purine metabolism) are clearly incompatible with a membrane-associated terpene cyclase from a fungal secondary-metabolite gene cluster. No other option is defensible for this sequence."
  },
  "important_caveats": [
    "The evidence code ECO:0000269 indicates experimental evidence, but the underlying experiment (2021 JACS paper) primarily involved genome mining, heterologous expression, and chemical characterization; the 'antifungal' label reflects the product's biological activity rather than a dedicated antifungal-pathway assay.",
    "The pathway name 'Antifungal biosynthesis' is a UniProt-specific annotation convention; the same enzyme could reasonably be placed under 'terpene biosynthesis' or 'natural product biosynthesis' in other databases.",
    "The UniProt entry was first public in Feb 2025; the author's source snapshot is unknown, but the sequence matches both current (v4) and historical (v2) records.",
    "The terpene cyclase DDxxD/NDxxD motifs are not clearly identifiable by simple pattern matching in this sequence, making positive enzymatic classification from sequence alone difficult."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> A sequence-matched UniProt annotation assigns the protein to antifungal biosynthesis and cites experimental evidence (ECO:0000269). This supports B, though the cited study was not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is strongly hydrophobic and appears to encode a multipass membrane protein. That makes a ribosomal elongation role and many typical folate- or purine-metabolism enzymes less plausible, but it does not specifically indicate antifungal biosynthesis.


**Missing item-specific fact**

> The sequence's membership and role in an antifungal biosynthetic pathway are not supplied; establishing that association requires target-specific annotation or evidence.


**Reason**

> The sequence offers a weak filter against some alternatives, but no recognizable family feature or pathway-specific motif meaningfully distinguishes antifungal biosynthesis from the listed choices. The decisive pathway association is a fact about this protein not inferable from the provided context.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied source annotation supports B; no competing option is supported by the available evidence.


### Important caveats

- The source annotation is sequence-matched and cites experimental evidence, but the cited primary study was not independently assessed.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is strongly hydrophobic and appears to encode a multipass membrane protein. That makes a ribosomal elongation role and many typical folate- or purine-metabolism enzymes less plausible, but it does not specifically indicate antifungal biosynthesis.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The sequence's membership and role in an antifungal biosynthetic pathway are not supplied; establishing that association requires target-specific annotation or evidence.",
    "reason": "The sequence offers a weak filter against some alternatives, but no recognizable family feature or pathway-specific motif meaningfully distinguishes antifungal biosynthesis from the listed choices. The decisive pathway association is a fact about this protein not inferable from the provided context."
  },
  "case_id": "pathway_0010",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "A sequence-matched UniProt annotation assigns the protein to antifungal biosynthesis and cites experimental evidence (ECO:0000269). This supports B, though the cited study was not independently reviewed here."
  },
  "important_caveats": [
    "The source annotation is sequence-matched and cites experimental evidence, but the cited primary study was not independently assessed."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied source annotation supports B; no competing option is supported by the available evidence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0010",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "A sequence-matched UniProt annotation assigns the protein to antifungal biosynthesis and cites experimental evidence (ECO:0000269). This supports B, though the cited study was not independently reviewed here.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is strongly hydrophobic and appears to encode a multipass membrane protein. That makes a ribosomal elongation role and many typical folate- or purine-metabolism enzymes less plausible, but it does not specifically indicate antifungal biosynthesis.",
    "missing_item_specific_fact": "The sequence's membership and role in an antifungal biosynthetic pathway are not supplied; establishing that association requires target-specific annotation or evidence.",
    "reason": "The sequence offers a weak filter against some alternatives, but no recognizable family feature or pathway-specific motif meaningfully distinguishes antifungal biosynthesis from the listed choices. The decisive pathway association is a fact about this protein not inferable from the provided context."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied source annotation supports B; no competing option is supported by the available evidence."
  },
  "important_caveats": [
    "The source annotation is sequence-matched and cites experimental evidence, but the cited primary study was not independently assessed."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P9WEG7 (RSTN5_ASPN3) annotates this 349-aa protein as 'Terpene cyclase rstn5' / 'Restricticin biosynthesis cluster protein 5' with EC 5.4.99.-. The PATHWAY comment explicitly states 'Antifungal biosynthesis' with experimental evidence code ECO:0000269 from PubMed:33857369 (Liu et al., JACS 2021, on CYP51-inhibitor biosynthetic gene clusters). The sequence matches the benchmark input exactly. Choice B is directly supported by the curated annotation backed by experimental evidence.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence can be eliminated against options A, C, and D using well-known protein-family features. (1) Option A (polypeptide chain elongation): ribosomal proteins and elongation factors (EF-Tu, EF-G, eEF1A) are highly conserved, relatively hydrophilic, and lack N-terminal signal peptides. This sequence begins with a clear hydrophobic signal peptide (MLHLTPLIFLSLAMAAAVGVWGVFTWNGG) and is dominated by membrane-spanning hydrophobic stretches—completely inconsistent with ribosomal/elongation machinery. (2) Option C (tetrahydrofolate interconversion): DHFR, SHMT, methylenetetrahydrofolate dehydrogenase, etc., share a Rossmann fold (GxGxxG) or specific folate-binding motifs. No such motif is present. (3) Option D (purine metabolism): PRPP synthetase, IMP dehydrogenase, phosphoribosyltransferases have characteristic PRPP-binding loops and specific catalytic residues absent here. (4) The remaining sequence features—multiple transmembrane-like helices, a GDF motif (variant of the DDxxD/NDxxD terpenoid cyclase signature), ~350 aa length, and membrane association—are hallmarks of fungal membrane-associated terpene cyclases involved in natural-product biosynthesis. Among the four offered choices, only 'Antifungal biosynthesis' (B) is compatible with a membrane-bound terpene cyclase. The elimination of A, C, D relies on canonical structural/sequence signatures of those protein classes, which is transferable knowledge from other proteins.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model can eliminate ribosomal/elongation proteins, folate enzymes, and purine metabolism enzymes based on the absence of their hallmark motifs (Rossmann fold, PRPP-binding, ribosomal protein conservation) and the presence of a signal peptide plus multiple hydrophobic helices. The residual option B is the only one consistent with a membrane-associated terpene cyclase. While positively naming the pathway 'Antifungal biosynthesis' rather than generic 'terpenoid biosynthesis' is specific, the multiple-choice format makes elimination sufficient to select B.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, C, and D are clearly incompatible with the sequence features (signal peptide, membrane helices, absence of Rossmann/PRPP/ribosomal motifs). Only B remains viable among the four choices. No ambiguity among the offered alternatives.


### Important caveats

- The pathway label 'Antifungal biosynthesis' is a UniProt-specific curated term; a model might more naturally call this 'terpenoid/secondary metabolite biosynthesis.' However, among the four given options, elimination uniquely selects B.
- The GDF motif is a variant of the canonical DDxxD/NDxxD terpenoid cyclase motif; identification as a terpene cyclase from sequence alone is suggestive but not definitive without structural confirmation.
- The UniProt annotation is backed by experimental evidence (ECO:0000269, PubMed:33857369), confirming the pathway assignment.
- The entry was first released in 2025; the benchmark author's source snapshot date is unknown, but the sequence matches both current and historical (entry v2) records.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence can be eliminated against options A, C, and D using well-known protein-family features. (1) Option A (polypeptide chain elongation): ribosomal proteins and elongation factors (EF-Tu, EF-G, eEF1A) are highly conserved, relatively hydrophilic, and lack N-terminal signal peptides. This sequence begins with a clear hydrophobic signal peptide (MLHLTPLIFLSLAMAAAVGVWGVFTWNGG) and is dominated by membrane-spanning hydrophobic stretches—completely inconsistent with ribosomal/elongation machinery. (2) Option C (tetrahydrofolate interconversion): DHFR, SHMT, methylenetetrahydrofolate dehydrogenase, etc., share a Rossmann fold (GxGxxG) or specific folate-binding motifs. No such motif is present. (3) Option D (purine metabolism): PRPP synthetase, IMP dehydrogenase, phosphoribosyltransferases have characteristic PRPP-binding loops and specific catalytic residues absent here. (4) The remaining sequence features—multiple transmembrane-like helices, a GDF motif (variant of the DDxxD/NDxxD terpenoid cyclase signature), ~350 aa length, and membrane association—are hallmarks of fungal membrane-associated terpene cyclases involved in natural-product biosynthesis. Among the four offered choices, only 'Antifungal biosynthesis' (B) is compatible with a membrane-bound terpene cyclase. The elimination of A, C, D relies on canonical structural/sequence signatures of those protein classes, which is transferable knowledge from other proteins.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can eliminate ribosomal/elongation proteins, folate enzymes, and purine metabolism enzymes based on the absence of their hallmark motifs (Rossmann fold, PRPP-binding, ribosomal protein conservation) and the presence of a signal peptide plus multiple hydrophobic helices. The residual option B is the only one consistent with a membrane-associated terpene cyclase. While positively naming the pathway 'Antifungal biosynthesis' rather than generic 'terpenoid biosynthesis' is specific, the multiple-choice format makes elimination sufficient to select B."
  },
  "case_id": "pathway_0010",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P9WEG7 (RSTN5_ASPN3) annotates this 349-aa protein as 'Terpene cyclase rstn5' / 'Restricticin biosynthesis cluster protein 5' with EC 5.4.99.-. The PATHWAY comment explicitly states 'Antifungal biosynthesis' with experimental evidence code ECO:0000269 from PubMed:33857369 (Liu et al., JACS 2021, on CYP51-inhibitor biosynthetic gene clusters). The sequence matches the benchmark input exactly. Choice B is directly supported by the curated annotation backed by experimental evidence."
  },
  "important_caveats": [
    "The pathway label 'Antifungal biosynthesis' is a UniProt-specific curated term; a model might more naturally call this 'terpenoid/secondary metabolite biosynthesis.' However, among the four given options, elimination uniquely selects B.",
    "The GDF motif is a variant of the canonical DDxxD/NDxxD terpenoid cyclase motif; identification as a terpene cyclase from sequence alone is suggestive but not definitive without structural confirmation.",
    "The UniProt annotation is backed by experimental evidence (ECO:0000269, PubMed:33857369), confirming the pathway assignment.",
    "The entry was first released in 2025; the benchmark author's source snapshot date is unknown, but the sequence matches both current and historical (entry v2) records."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, C, and D are clearly incompatible with the sequence features (signal peptide, membrane helices, absence of Rossmann/PRPP/ribosomal motifs). Only B remains viable among the four choices. No ambiguity among the offered alternatives."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0010",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P9WEG7 (RSTN5_ASPN3) annotates this 349-aa protein as 'Terpene cyclase rstn5' / 'Restricticin biosynthesis cluster protein 5' with EC 5.4.99.-. The PATHWAY comment explicitly states 'Antifungal biosynthesis' with experimental evidence code ECO:0000269 from PubMed:33857369 (Liu et al., JACS 2021, on CYP51-inhibitor biosynthetic gene clusters). The sequence matches the benchmark input exactly. Choice B is directly supported by the curated annotation backed by experimental evidence.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence can be eliminated against options A, C, and D using well-known protein-family features. (1) Option A (polypeptide chain elongation): ribosomal proteins and elongation factors (EF-Tu, EF-G, eEF1A) are highly conserved, relatively hydrophilic, and lack N-terminal signal peptides. This sequence begins with a clear hydrophobic signal peptide (MLHLTPLIFLSLAMAAAVGVWGVFTWNGG) and is dominated by membrane-spanning hydrophobic stretches—completely inconsistent with ribosomal/elongation machinery. (2) Option C (tetrahydrofolate interconversion): DHFR, SHMT, methylenetetrahydrofolate dehydrogenase, etc., share a Rossmann fold (GxGxxG) or specific folate-binding motifs. No such motif is present. (3) Option D (purine metabolism): PRPP synthetase, IMP dehydrogenase, phosphoribosyltransferases have characteristic PRPP-binding loops and specific catalytic residues absent here. (4) The remaining sequence features—multiple transmembrane-like helices, a GDF motif (variant of the DDxxD/NDxxD terpenoid cyclase signature), ~350 aa length, and membrane association—are hallmarks of fungal membrane-associated terpene cyclases involved in natural-product biosynthesis. Among the four offered choices, only 'Antifungal biosynthesis' (B) is compatible with a membrane-bound terpene cyclase. The elimination of A, C, D relies on canonical structural/sequence signatures of those protein classes, which is transferable knowledge from other proteins.",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can eliminate ribosomal/elongation proteins, folate enzymes, and purine metabolism enzymes based on the absence of their hallmark motifs (Rossmann fold, PRPP-binding, ribosomal protein conservation) and the presence of a signal peptide plus multiple hydrophobic helices. The residual option B is the only one consistent with a membrane-associated terpene cyclase. While positively naming the pathway 'Antifungal biosynthesis' rather than generic 'terpenoid biosynthesis' is specific, the multiple-choice format makes elimination sufficient to select B."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, C, and D are clearly incompatible with the sequence features (signal peptide, membrane helices, absence of Rossmann/PRPP/ribosomal motifs). Only B remains viable among the four choices. No ambiguity among the offered alternatives."
  },
  "important_caveats": [
    "The pathway label 'Antifungal biosynthesis' is a UniProt-specific curated term; a model might more naturally call this 'terpenoid/secondary metabolite biosynthesis.' However, among the four given options, elimination uniquely selects B.",
    "The GDF motif is a variant of the canonical DDxxD/NDxxD terpenoid cyclase motif; identification as a terpene cyclase from sequence alone is suggestive but not definitive without structural confirmation.",
    "The UniProt annotation is backed by experimental evidence (ECO:0000269, PubMed:33857369), confirming the pathway assignment.",
    "The entry was first released in 2025; the benchmark author's source snapshot date is unknown, but the sequence matches both current and historical (entry v2) records."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "P9WEG7",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "81e62647611dee5222b170056638bacd813b9736ff263a1893b00f2e83d6464a",
  "benchmark_sequence_length": 349,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 4,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "cc0cb3cc56cbc60432581eb408108dc2d2be5bfdc4ea3d2699b2708dcea8ab8b",
  "current_source_sequence_sha256": "81e62647611dee5222b170056638bacd813b9736ff263a1893b00f2e83d6464a",
  "current_source_sequence_length": 349,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 2,
  "selected_historical_version": {
    "accession": "P9WEG7",
    "database": "Swiss-Prot",
    "entryVersion": 2,
    "firstRelease": "2025_02/2025_02",
    "firstReleaseDate": "23-Apr-2025",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "RSTN5_ASPN3",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "20bc0e67398f5d9ca5428fba937ca2d4cf4546b725019108174063d3acb20d32",
  "selected_historical_source_sequence_sha256": "81e62647611dee5222b170056638bacd813b9736ff263a1893b00f2e83d6464a",
  "selected_historical_source_sequence_length": 349,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 2,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG7.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P9WEG7.json",
  "source_sha256": "cc0cb3cc56cbc60432581eb408108dc2d2be5bfdc4ea3d2699b2708dcea8ab8b",
  "retrieved_utc": "2026-11-02T04:30:17.512806+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"P9WEG7\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG7.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P9WEG7.json",
  "source_sha256": "cc0cb3cc56cbc60432581eb408108dc2d2be5bfdc4ea3d2699b2708dcea8ab8b",
  "retrieved_utc": "2026-11-02T04:30:17.512806+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":4,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG7.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P9WEG7.json",
  "source_sha256": "cc0cb3cc56cbc60432581eb408108dc2d2be5bfdc4ea3d2699b2708dcea8ab8b",
  "retrieved_utc": "2026-11-02T04:30:17.512806+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Eurotiomycetes\",\"Eurotiomycetidae\",\"Eurotiales\",\"Aspergillaceae\",\"Aspergillus\",\"Circumdati\"],\"scientificName\":\"Aspergillus nomiae NRRL (strain ATCC 15546 / NRRL 13137 / CBS 260.88 / M93)\",\"taxonId\":1509407}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG7.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P9WEG7.json",
  "source_sha256": "cc0cb3cc56cbc60432581eb408108dc2d2be5bfdc4ea3d2699b2708dcea8ab8b",
  "retrieved_utc": "2026-11-02T04:30:17.512806+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Restricticin biosynthesis cluster protein 5\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"5.4.99.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Terpene cyclase rstn5\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG7.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P9WEG7.json",
  "source_sha256": "cc0cb3cc56cbc60432581eb408108dc2d2be5bfdc4ea3d2699b2708dcea8ab8b",
  "retrieved_utc": "2026-11-02T04:30:17.512806+00:00",
  "json_pointer": "/comments/1",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG7.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P9WEG7.json",
  "source_sha256": "cc0cb3cc56cbc60432581eb408108dc2d2be5bfdc4ea3d2699b2708dcea8ab8b",
  "retrieved_utc": "2026-11-02T04:30:17.512806+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu N.\",\"Abramyan E.D.\",\"Cheng W.\",\"Perlatti B.\",\"Harvey C.J.B.\",\"Bills G.F.\",\"Tang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"33857369\"},{\"database\":\"DOI\",\"id\":\"10.1021/jacs.1c01516\"}],\"citationType\":\"journal article\",\"firstPage\":\"6043\",\"id\":\"33857369\",\"journal\":\"J. Am. Chem. Soc.\",\"lastPage\":\"6047\",\"publicationDate\":\"2021\",\"title\":\"Targeted genome mining reveals the biosynthetic gene clusters of natural product CYP51 inhibitors.\",\"volume\":\"143\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P9WEG7?format=txt&versions=2)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P9WEG7?format=txt&versions=2",
  "source_sha256": "20bc0e67398f5d9ca5428fba937ca2d4cf4546b725019108174063d3acb20d32",
  "retrieved_utc": "2026-11-02T04:30:21.947384+00:00",
  "source_locator": "lines 1-15",
  "excerpt": "ID   RSTN5_ASPN3             Reviewed;         349 AA.\nAC   P9WEG7;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   09-APR-2025, entry version 2.\nDE   RecName: Full=Terpene cyclase rstn5 {ECO:0000303|PubMed:33857369};\nDE            EC=5.4.99.- {ECO:0000305|PubMed:33857369};\nDE   AltName: Full=Restricticin biosynthesis cluster protein 5 {ECO:0000303|PubMed:33857369};\nGN   Name=rstn5 {ECO:0000303|PubMed:33857369};\nOS   Aspergillus nomiae NRRL (strain ATCC 15546 / NRRL 13137 / CBS 260.88 /\nOS   M93).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;\nOC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;\nOC   Aspergillus subgen. Circumdati.\nOX   NCBI_TaxID=1509407;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P9WEG7?format=txt&versions=2)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P9WEG7?format=txt&versions=2",
  "source_sha256": "20bc0e67398f5d9ca5428fba937ca2d4cf4546b725019108174063d3acb20d32",
  "retrieved_utc": "2026-11-02T04:30:21.947384+00:00",
  "source_locator": "lines 24-31",
  "excerpt": "RN   [2]\nRP   FUNCTION, AND PATHWAY.\nRX   PubMed=33857369; DOI=10.1021/jacs.1c01516;\nRA   Liu N., Abramyan E.D., Cheng W., Perlatti B., Harvey C.J.B., Bills G.F.,\nRA   Tang Y.;\nRT   \"Targeted genome mining reveals the biosynthetic gene clusters of natural\nRT   product CYP51 inhibitors.\";\nRL   J. Am. Chem. Soc. 143:6043-6047(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P9WEG7?format=txt&versions=2)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P9WEG7?format=txt&versions=2",
  "source_sha256": "20bc0e67398f5d9ca5428fba937ca2d4cf4546b725019108174063d3acb20d32",
  "retrieved_utc": "2026-11-02T04:30:21.947384+00:00",
  "source_locator": "lines 47-47",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:33857369}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 10. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
